8-K filing — Twist Bioscience Corp (TWST)
Filed: 2026-08-19 AccNo: 0001104659-26-098830 Size: 214 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $115
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $113 to $115.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 4, 2026, 10:37 AM
- Checked
- Aug 4, 2026, 10:37 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report
TWST shares surge after Anthropic names the company an independent evaluator in a new AI-driven protein design campaign. The bullish momentum overshadows a critical short report published on X by activist short-seller Scorpion Capital.
Read original at benzingaWatching Twist Bioscience; Scorpion Capital Issues Report On Co, States They Hold A Short Position
https://x.com/ScorpionFund/status/2090160099520348644?s=20
Read original at benzingaTwist Bioscience Stock Hits 52-Week High - Here's Why
Twist Bioscience (TWST) stock jumped 17% after Anthropic chose the firm to test AI-designed proteins. Get the full market update.
Read original at benzinga